Skip to content

The Lóa Study: A Brief Digital Intervention for Women With Intrusive Memories in the SAGA Cohort

The Lóa Study: A Randomised Control Trial of a Brief Digital Intervention to Support Women Experiencing Intrusive Memories of Traumatic Events During Their Lifespan From the SAGA Cohort

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05849337
Enrollment
380
Registered
2023-05-08
Start date
2023-10-30
Completion date
2026-09-30
Last updated
2026-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrusive Memories of Traumatic Event(s)

Brief summary

Intrusive memories are sensory memories of a traumatic event(s) that spring to mind involuntarily, and can evoke strong emotions and disrupt functioning in daily life. Previous research has indicated that a brief cognitive intervention can prevent the development of intrusive memories as well as reduce the number of intrusive memories of long-standing trauma. Initial pilot work (using case studies and a pilot study, ClinicalTrials.gov identifier: NCT05089058) with women in Iceland indicates that the intervention is acceptable and feasible. This randomised controlled trial will compare 3 arms to investigate if access to a cognitive task - either a brief self-guided imagery-competing task or a brief self-guided psychoeducation and signposting task - versus treatment as usual, can reduce the number of intrusive memories in week 5 (i.e., between-groups comparison), controlling for the number of intrusive memories in the baseline week. The effect on the number of intrusive memories in week 5 (primary outcome), and other symptoms of post-traumatic stress, sleep and cognitive functioning will be tested. This study is funded by the Icelandic Research Fund (11709-0270) and (200095-5601) and The Oak Foundation (OCAY-18-442).

Detailed description

Participants will be recruited from the Stress and Gene Analysis (SAGA) Cohort, a population-based, longitudinal study of Icelandic women (www.afallasaga.is, see selected publications in the reference box below). A statistical analysis plan will be prepared prior to the first interim analysis using both frequentist and Bayesian analyses for statistical inference. Regular monitoring will be performed by Vistor to verify that the study is conducted, and data are generated, documented and reported in compliance with the protocol, good clinical practice (GCP) and the applicable regulatory guidelines.

Interventions

BEHAVIORALBrief imagery-competing task

Two digital self-guided sessions of a brief digital imagery-competing task. A memory cue followed by playing a computer game with mental rotation instructions.

BEHAVIORALBrief psychoeducation and signposting task

Two digital self-guided sessions and access to psychoeducation and signposting regarding resources for psychological trauma in Iceland.

OTHERTreatment as usual (TAU)

Routine care that participants would otherwise receive if having intrusive memories of traumatic events

Sponsors

University of Iceland
Lead SponsorOTHER
Uppsala University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 73 Years
Healthy volunteers
Yes

Inclusion criteria

* Part of the SAGA cohort * Aged 18 or above. * Able to read, write and speak in Icelandic. * Have internet access. * Willing to be contacted remotely and having access to a smartphone or computer * Experience 3 or more intrusive memories in the past week * Willing to monitor intrusive memories in everyday life * Willing and able to provide informed consent and complete study procedures * Willing and able to be contacted by the research team during the study period. * Have not taken part in a previous study of this intervention from this research team (e.g., the Loa case series, feasibility trial or pilot RCT).

Exclusion criteria

* Have fewer than three intrusive memories during the baseline week. * Suicide risk in the initial assessment (response of 'nearly every day' to item 9 on PHQ-9). * Those undergoing other treatments for post-traumatic stress disorder (PTSD) or its symptoms will not be excluded, so the study will be as inclusive as possible.

Design outcomes

Primary

MeasureTime frameDescription
Number of intrusive memories of traumatic event(s)Week 5 (all arms) controlling for run-in/baseline weekThe number of intrusive memories of traumatic events recorded by participants in a brief daily online intrusive memory diary for 7 days.

Secondary

MeasureTime frameDescription
Number of intrusive memories of the traumatic event(s)Week 12 and week 24 follow-ups (all arms) controlling for run-in/baseline weekThe number of intrusive memories of traumatic events recorded by participants in a brief daily online intrusive memory diary for 7 days.
The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)Baseline, week 5, week 12 and week 24 follow-upsA 20-item questionnaire assessing the severity of PTSD symptoms corresponding to the DSM-5 criteria for PTSD. Items are rated on a 5-point Likert scale ranging from 0 ("not at all") to 4 ("extremely"). Scores are summed to give a total severity score (ranging 0 to 80).
The Pittsburgh Sleep Quality Index Addendum for PTSD (PSQI-A)Baseline, week 5, week 12 and week 24 follow-upsA 7-item questionnaire assessing the frequency of disruptive nocturnal behaviours (e.g., acting out dreams, episodes of terror or screaming). Respondents report symptoms over the past month on a 4-point Likert scale, ranging from 0 ("never in the past month") to 3 ("three or more times each week"). Total score ranges from 0 to 21 with higher scores indicating worse symptoms.
Cognitive Functions ScaleBaseline, week 5, week 12 and week 24 follow-upsAn 11 item questionnaire about cognitive functions in particular memory and concentration. Items are rated on a 5-point scale, from 1 ("every day") to 5 ("never"). Total scores range from 11 to 55; higher scores indicate less concentration and memory difficulties.

Countries

Iceland

Contacts

PRINCIPAL_INVESTIGATORArna Hauksdóttir, PhD

University of Iceland

PRINCIPAL_INVESTIGATOREmily Holmes, PhD

Uppsala University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 8, 2026